Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

NCT07216976 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.

NCT NCT07216976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07216976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study
Lead sponsor
MedtronicNeuro
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 19, 2025
Completion date
January 31, 2028
Enrollment
61 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease